Biolife Solutions (BLFS) Net Margin (2010 - 2026)

Biolife Solutions (BLFS) has reported Net Margin for 17 consecutive years, with 158.45% the latest figure, recorded in Q2 2026.

• On a quarterly basis, Net Margin rose 22602.0% year-over-year to 158.45% in Q2 2026; TTM through Jun 2026 was 56.35%, a 6310.0% increase from a year earlier, with the FY2025 full-year figure at 4.78%, up 2226.0% from the prior year.
• Net Margin was 158.45% for Q2 2026 at Biolife Solutions, up from 4.17% in the prior quarter.
• Over five years, Net Margin peaked at 158.45% in Q2 2026 and troughed at 179.8% in Q2 2022.
• A 5-year average of 7.63% and a median of 14.22% in 2022 frame the typical range for Net Margin.
• Across the five-year window, Net Margin plunged 20504 bps in 2022 and jumped 22602 bps in 2026, its largest moves.
• Over 5 years, Net Margin stood at 119.21% in 2022, then declined by 20 bps to 95.75% in 2023, then retreated by 14 bps to 82.47% in 2024, then decreased by 29 bps to 58.93% in 2025, then surged by 169 bps to 158.45% in 2026.
• The last three Net Margin figures came in at 158.45% (Q2 2026), 4.17% (Q1 2026), and 58.93% (Q4 2025), per Business Quant data.